pimafucort and Otitis-Externa

External otitis accounts for 21 to 25% of all inflammatory ear diseases. This paper presents the original data providing a deeper insight into etiology of this disease taking into consideration the great variety of its pathogenic agents, the possibility of development of mixed forms, and changes of whether conditions at the peak of morbidity. In addition, the results of assessment of the efficacy of Pimafucort designed for both mono- and combined therapy of the disease of interest are reported.

Topics: Adolescent; Child; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Male; Natamycin; Neomycin; Otitis Externa

This clinical study was designed to estimate the efficacy and tolerability of the locally applied Pimafucort preparation for the treatment of diffuse otitis of bacterial and mycotic origin. The results of dynamic bacteriological investigation in conjunction with clinical observations give reason to recommend the local therapy as the sole treatment of uncomplicated forms of diffuse external otitis.

Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Drug Combinations; Female; Humans; Hydrocortisone; Male; Middle Aged; Mycoses; Natamycin; Neomycin; Otitis Externa; Young Adult

Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Dermatology; Drug Combinations; Drug Therapy, Combination; Ear Canal; Eczema; Female; Follow-Up Studies; Humans; Hydrocortisone; Male; Middle Aged; Natamycin; Neomycin; Ointments; Otitis Externa; Treatment Outcome